| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.36B | 46.69B | 41.56B | 39.33B | 35.88B | 30.69B |
| Gross Profit | 18.40B | 18.86B | 17.85B | 16.49B | 14.22B | 12.01B |
| EBITDA | 11.90B | 12.19B | 11.69B | 10.75B | 8.94B | 7.09B |
| Net Income | 8.81B | 9.64B | 8.68B | 7.92B | 6.29B | 4.69B |
Balance Sheet | ||||||
| Total Assets | 62.55B | 71.24B | 63.49B | 57.39B | 49.35B | 43.39B |
| Cash, Cash Equivalents and Short-Term Investments | 22.94B | 29.25B | 23.56B | 20.34B | 16.95B | 15.76B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.73B | 8.29B | 7.79B | 7.47B | 7.42B | 6.57B |
| Stockholders Equity | 55.81B | 62.95B | 55.70B | 49.92B | 41.93B | 36.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.85B | 6.42B | 6.20B | 2.98B | 5.24B |
| Operating Cash Flow | 0.00 | 9.05B | 8.46B | 7.55B | 5.69B | 5.43B |
| Investing Cash Flow | 0.00 | -425.00M | -2.61B | -3.69B | -2.28B | -1.02B |
| Financing Cash Flow | 0.00 | -3.15B | -2.63B | -1.99B | -1.74B | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥113.31B | 10.81 | ― | 3.01% | 12.35% | 11.03% | |
81 Outperform | ¥236.02B | 8.29 | ― | 3.36% | 4.89% | 44.89% | |
74 Outperform | ¥526.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
72 Outperform | ¥141.13B | 16.02 | ― | 2.93% | 3.63% | 35.38% | |
68 Neutral | ¥208.54B | 29.39 | ― | 4.77% | -3.95% | -13.75% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥397.21B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% |